|
1
|
Dela Cruz CS, Tanoue LT and Matthay RA:
Lung cancer: Epidemiology, etiology, and prevention. Clin Chest
Med. 32:605–644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tirino V, Desiderio V, Paino F, De Rosa A,
Papaccio F, La Noce M, Laino L, De Francesco F and Papaccio G:
Cancer stem cells in solid tumors: An overview and new approaches
for their isolation and characterization. FASEB J. 27:13–24. 2013.
View Article : Google Scholar
|
|
5
|
Weiswald LB, Bellet D and Dangles-Marie V:
Spherical cancer models in tumor biology. Neoplasia. 17:1–15. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamamuro S, Okamoto Y, Sano E, Ochiai Y,
Ogino A, Ohta T, Hara H, Ueda T, Nakayama T, Yoshino A and Katayama
Y: Characterization of glioma stem-like cells from human
glioblastomas. Int J Oncol. 47:91–96. 2015.PubMed/NCBI
|
|
7
|
Iacopino F, Angelucci C, Piacentini R,
Biamonte F, Mangiola A, Maira G, Grassi C and Sica G: Isolation of
cancer stem cells from three human glioblastoma cell lines:
Characterization of two selected clones. PLoS One. 9:e1051662014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zakaria N, Yusoff NM, Zakaria Z, Lim MN,
Baharuddin PJ, Fakiruddin KS and Yahaya B: Human non-small cell
lung cancer expresses putative cancer stem cell markers and
exhibits the transcriptomic profile of multipotent cells. BMC
Cancer. 15:842015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Alamgeer M, Peacock CD, Matsui W, Ganju V
and Watkins DN: Cancer stem cells in lung cancer: Evidence and
controversies. Respirology. 18:757–764. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:504–514. 2008.
View Article : Google Scholar
|
|
11
|
Grosse-Gehling P, Fargeas CA, Dittfeld C,
Garbe Y, Alison MR, Corbeil D and Kunz-Schughart LA: CD133 as a
biomarker for putative cancer stem cells in solid tumors:
Limitations, problems and challenges. J Pathol. 229:355–378. 2013.
View Article : Google Scholar
|
|
12
|
Cioffi M, D'Alterio C, Camerlingo R,
Tirino V, Consales C, Riccio A, Ieranò C, Cecere SC, Losito NS,
Greggi S, et al: Identification of a distinct population of
CD133(+)CXCR4(+) cancer stem cells in ovarian cancer. Sci Rep.
5:103572015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kashihara H, Shimada M, Kurita N, Iwata T,
Sato H, Kozo Yoshikawa, Higashijima J, Chikakiyo M, Nishi M and
Matsumoto N: CD133 expression is correlated with poor prognosis in
colorectal cancer. Hepatogastroenterology. 61:1563–1567.
2014.PubMed/NCBI
|
|
14
|
Nomura A, Banerjee S, Chugh R, Dudeja V,
Yamamoto M, Vickers SM and Saluja AK: CD133 initiates tumors,
induces epithelial-mesenchymal transition and increases metastasis
in pancreatic cancer. Oncotarget. 6:8313–8322. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nosrati A, Naghshvar F and Khanari S:
Cancer stem cell markers CD44, CD133 in primary gastric
adenocarcinoma. Int J Mol Cell Med. 3:279–286. 2014.
|
|
16
|
Yin S, Li J, Hu C, Chen X, Yao M, Yan M,
Jiang G, Ge C, Xie H, Wan D, et al: CD133 positive hepatocellular
carcinoma cells possess high capacity for tumorigenicity. Int J
Cancer. 120:1444–1450. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feng BH, Liu AG, Gu WG, Deng L, Cheng XG,
Tong TJ and Zhang HZ: CD133+ subpopulation of the HT1080 human
fibrosarcoma cell line exhibits cancer stem-like characteristics.
Oncol Rep. 30:815–823. 2013.PubMed/NCBI
|
|
18
|
Nakanishi T and Ross DD: Breast cancer
resistance protein (BCRP/ABCG2): Its role in multidrug resistance
and regulation of its gene expression. Chin J Cancer. 31:73–99.
2012. View Article : Google Scholar
|
|
19
|
Robey RW, To KK, Polgar O, Dohse M, Fetsch
P, Dean M and Bates SE: ABCG2: A perspective. Adv Drug Deliv Rev.
61:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sicchieri RD, da Silveira WA, Mandarano
LR, Gonçalves de Oliveira TM, Carrara HH, Muglia VF, de Andrade JM
and Tiezzi DG: ABCG2 is a potential marker of tumor-initiating
cells in breast cancer. Tumor Biol. 36:9233–9243. 2015. View Article : Google Scholar
|
|
21
|
Ballester M1, Castelló A, Ibáñez E,
Sánchez A and Folch JM: Real-time quantitative PCR-based system for
determining transgene copy number in transgenic animals.
Biotechniques. 37:610–613. 2004.PubMed/NCBI
|
|
22
|
Williams GH and Stoeber K: The cell cycle
and cancer. J Pathol. 226:352–364. 2012. View Article : Google Scholar
|
|
23
|
Abdullah LN and Chow EK: Mechanisms of
chemoresistance in cancer stem cells. Clin Transl Med. 2:32013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
26
|
Piscitelli E, Cocola C, Thaden FR,
Pelucchi P, Gray B, Bertalot G, Albertini A, Reinbold R and Zucchi
I: Culture and characterization of mammary cancer stem cells in
mammospheres. Methods Mol Biol. 1235:243–262. 2015. View Article : Google Scholar
|
|
27
|
House CD, Hernandez L and Annunziata CM:
In vitro enrichment of ovarian cancer tumor-initiating cells. J Vis
Exp. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fredebohm J, Boettcher M, Eisen C, Gaida
MM, Heller A, Keleg S, Tost J, Greulich-Bode KM, Hotz-Wagenblatt A,
Lathrop M, et al: Establishment and characterization of a highly
tumorigenic and cancer stem cell enriched pancreatic cancer cell
line as a well defined model system. PLoS One. 7:e485032012.
View Article : Google Scholar
|
|
29
|
Fujiwara D, Kato K, Nohara S, Iwanuma Y
and Kajiyama Y: The usefulness of three-dimensional cell culture in
induction of cancer stem cells from esophageal squamous cell
carcinoma cell lines. Biochem Biophys Res Commun. 434:773–778.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu L, Zhang W, Wang J and Liu R: Evidence
of CD90+CXCR4+ cells as circulating tumor stem cells in
hepatocellular carcinoma. Tumor Biol. 36:5353–5360. 2015.
View Article : Google Scholar
|
|
31
|
Saha A, Shree Padhi S, Roy S and Banerjee
B: HCT116 colonospheres shows elevated expression of hTERT and
β-catenin protein-a short report. J Stem Cells. 9:243–251.
2014.
|
|
32
|
Liu J, Ma L, Xu J, Liu C, Zhang J, Liu J,
Chen R and Zhou Y: Sphere-forming body-forming cells in the human
gastric cancer cell line MKN-45 possess cancer stem cell
properties. Int J Oncol. 42:453–459. 2013.
|
|
33
|
Castillo V, Valenzuela R, Huidobro C,
Contreras HR and Castellon EA: Functional characteristics of cancer
stem cells and their role in drug resistance of prostate cancer.
Int J Oncol. 45:985–994. 2014.PubMed/NCBI
|
|
34
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells-perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
